Patent intelligence · IT
IT 201700031902
Composizione nutraceutica, dietetica e nutrizionale ad attività antiossidante.
Composizione nutraceutica, dietetica e nutrizionale ad attività antiossidante.
Patent details — IT 201700031902
- Jurisdiction
- IT
- Status
- granted
- Grant date
- Sep 23, 2018
- Expiration
- Sep 18, 2038
- CPC classes
- A61K 31/ 714 A I, A61K 36/ 68 A I, A61K/3101, A61K/31122
Quick answer
IT 201700031902 (Composizione nutraceutica, dietetica e nutrizionale ad attività antiossidante.) is held by A MENARINI IND FARMACEUTICHE RIUNITE S R L. Status: granted. Granted Sep 23, 2018. Expires Sep 18, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 714 A I, A61K 36/ 68 A I, A61K/3101, A61K/31122, A61K/31714, A61K/3668
More from A MENARINI IND FARMACEUTICHE RIUNITE S R L
Related pharmaceutical patents in our USPTO index.
-
CA 2682039
PREPARATIONS COSMETIQUES VISANT A REDUIRE LA CELLULITE DISGRACIEUSE
granted -
EP 1526849
TOPISCHE ZUSAMMENSETZUNG ENTHALTEND KETOPROFEN STABILISIERT MIT SULISOBENZON
expired -
AT E203027
PENEMDERIVATE, DEREN HERSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
expired -
US 6150325
Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical compositions
expired
Frequently asked questions
What is US patent 201700031902?
IT 201700031902 (Composizione nutraceutica, dietetica e nutrizionale ad attività antiossidante.) is held by A MENARINI IND FARMACEUTICHE RIUNITE S R L. Status: granted. Granted Sep 23, 2018. Expires Sep 18, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns IT 201700031902?
A MENARINI IND FARMACEUTICHE RIUNITE S R L is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 5 pharmaceutical patents for this assignee.
When does IT 201700031902 expire?
Our index shows an expiration date of Sep 18, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.